[go: up one dir, main page]

PT3365020T - Formulação de depósito de compósito de hidrogel. - Google Patents

Formulação de depósito de compósito de hidrogel.

Info

Publication number
PT3365020T
PT3365020T PT167946706T PT16794670T PT3365020T PT 3365020 T PT3365020 T PT 3365020T PT 167946706 T PT167946706 T PT 167946706T PT 16794670 T PT16794670 T PT 16794670T PT 3365020 T PT3365020 T PT 3365020T
Authority
PT
Portugal
Prior art keywords
depot formulation
hydrogel composite
composite depot
hydrogel
formulation
Prior art date
Application number
PT167946706T
Other languages
English (en)
Inventor
Jalonen Harry
Leino Lasse
Forsback Ari-Pekka
Jokinen Mika
Noppari Panu
Original Assignee
Delsitech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delsitech Oy filed Critical Delsitech Oy
Publication of PT3365020T publication Critical patent/PT3365020T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
PT167946706T 2015-10-22 2016-10-21 Formulação de depósito de compósito de hidrogel. PT3365020T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155750 2015-10-22

Publications (1)

Publication Number Publication Date
PT3365020T true PT3365020T (pt) 2019-10-24

Family

ID=57286528

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167946706T PT3365020T (pt) 2015-10-22 2016-10-21 Formulação de depósito de compósito de hidrogel.

Country Status (18)

Country Link
US (1) US10172792B2 (pt)
EP (1) EP3365020B1 (pt)
JP (1) JP6905520B2 (pt)
KR (1) KR102228986B1 (pt)
CN (1) CN108367076B (pt)
AU (1) AU2016342470B2 (pt)
BR (1) BR112018006784B1 (pt)
CA (1) CA3001752C (pt)
DK (1) DK3365020T3 (pt)
ES (1) ES2748032T3 (pt)
HR (1) HRP20191707T1 (pt)
HU (1) HUE046419T2 (pt)
LT (1) LT3365020T (pt)
MX (1) MX2018004797A (pt)
PL (1) PL3365020T3 (pt)
PT (1) PT3365020T (pt)
WO (1) WO2017068245A1 (pt)
ZA (1) ZA201802040B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111770763A (zh) * 2018-01-23 2020-10-13 埃森德生物制药有限公司 增强型病毒递送制剂
DE102020124430A1 (de) * 2019-09-19 2021-03-25 Amw Gmbh Extrudierte Depotform mit kontrollierter Wirkstofffreisetzung
US20230248647A1 (en) * 2020-07-07 2023-08-10 Delsitech Oy Silica hydrogel composite and its use
JP2024514824A (ja) * 2021-04-07 2024-04-03 ステルス バイオセラピューティクス インコーポレイテッド 治療用オリゴペプチドおよびペプチド模倣物のシリカベース製剤
WO2024047230A1 (en) 2022-09-01 2024-03-07 Optifye Therapeutics Ag Ophthalmic compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU738176B2 (en) 1996-05-29 2001-09-13 Delsitech Oy Dissolvable oxides for biological applications
CN101541939A (zh) * 2006-11-22 2009-09-23 阿普尔顿纸张公司 含有益剂的递送颗粒
CN101444503B (zh) * 2008-12-31 2011-02-02 江苏大学 一种水飞蓟宾高效长效制剂及其制法
US8974709B2 (en) * 2010-06-25 2015-03-10 Colabs Intl Corp Ceramic encapsulation with controlled layering by use of prehydrolyzed functionalized silanes
CN103687590A (zh) * 2011-04-28 2014-03-26 Stc·Unm公司 用于靶向给药的多孔纳米颗粒支撑脂双层(原始细胞)及其使用方法
KR101594820B1 (ko) 2011-06-16 2016-02-17 건일제약 주식회사 엔테카비르를 함유하는 미립구 및 이의 제조방법
ITTO20111242A1 (it) * 2011-12-30 2013-07-01 Miso S R L Composizioni per il trattamento di patologie delle mucose
HUE047897T2 (hu) * 2013-06-24 2020-05-28 Delsitech Oy Szilika tartalmú hidrogél kompozit
MX2016001607A (es) * 2013-08-06 2016-06-06 Dong Kook Pharm Co Ltd Microesferas de entecavir y composicion farmaceutica para administracion parenteral que contiene las mismas.

Also Published As

Publication number Publication date
ZA201802040B (en) 2019-07-31
KR102228986B1 (ko) 2021-03-18
CN108367076B (zh) 2021-08-31
KR20180071253A (ko) 2018-06-27
ES2748032T3 (es) 2020-03-12
US10172792B2 (en) 2019-01-08
BR112018006784B1 (pt) 2023-10-03
MX2018004797A (es) 2018-09-06
PL3365020T3 (pl) 2020-03-31
AU2016342470B2 (en) 2019-03-21
JP2018531270A (ja) 2018-10-25
CA3001752C (en) 2021-10-05
US20180311150A1 (en) 2018-11-01
HUE046419T2 (hu) 2020-02-28
EP3365020A1 (en) 2018-08-29
LT3365020T (lt) 2019-10-25
DK3365020T3 (da) 2019-10-07
AU2016342470A1 (en) 2018-04-12
CN108367076A (zh) 2018-08-03
JP6905520B2 (ja) 2021-07-21
WO2017068245A1 (en) 2017-04-27
EP3365020B1 (en) 2019-07-17
BR112018006784A2 (pt) 2018-10-16
HRP20191707T1 (hr) 2019-12-13
CA3001752A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
ZA201800029B (en) Microbiome-compatible cosmetics
GB201513010D0 (en) Novel formulation
PT3429644T (pt) Composição compatível com a pele
GB201505527D0 (en) Composition
SG11201705031VA (en) Hydrogel composition
SG11201708228YA (en) Lubricant composition
GB201506825D0 (en) Composition
ZA201802040B (en) Hydrogel composite depot formulation
GB201514758D0 (en) Formulation
GB201506757D0 (en) Cosmetic
GB201504665D0 (en) Composition
PT3173071T (pt) Formulação de maropitant
GB201521190D0 (en) Application in german
GB201504307D0 (en) Composition
HUE064128T2 (hu) Kenõanyag-készítmény
GB201519326D0 (en) Composition`
GB201505520D0 (en) Composition
ZA201901222B (en) Composition comprising duddingtonia flagrans
PL3405544T3 (pl) Nowa kompozycja kriogeniczna
PL3291820T3 (pl) Preparat hydrożelowy o łagodnej przyczepności
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
SG11201804517VA (en) Cosmetic composition
GB2538221B (en) Platform